FDA Inspection
Artivion, IncArtivion, Inc – FDA Inspection, Mar 31, 2023
Record Details
This FDA Inspection record concerns Artivion, Inc, with an inspection on March 31, 2023, issued by the Atlanta District Office.
- Company
- Artivion, Inc
- Inspection Date
- March 31, 2023
View Company Profile
ID · 43b3a45d-ac3b-451b-9704-99bd2ea7baa3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1201327
- FDA center
- Medical Devices & Rad Health
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 820.100(a)Lack of or inadequate procedures
- 21 CFR 820.30(f)Design verification - output does not meet input requirement
- 21 CFR 820.75(a)Documentation
- 21 CFR 820.90(a)Nonconforming product, Lack of or inadequate procedures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Artivion, Inc
14| Date | Classification | Office | Project area |
|---|---|---|---|
| September 15, 2026 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| March 22, 2024 | NAI | Center for Devices and Radiological Health | Compliance: Devices |
| August 29, 2023 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| January 20, 2022 | NAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
| August 8, 2018 | NAI | Center for Devices and Radiological Health | Postmarket Assurance: Devices |
Other documents for Artivion, Inc
- FDA Inspection 1337058 - 2026-09-15
- FDA Inspection 1237253 - 2024-03-22
- FDA Inspection 1218273 - 2023-08-29
- FDA Inspection 1161220 - 2022-01-20
- FDA Inspection 1061747 - 2018-08-08
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.